Clinical Trials

NCT07644754 | NOT_YET_RECRUITING | NA
27 participants

Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory Metastases

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-12
Start Date:
2026-07-31
Completion:
2027-07-31
Conditions
  • Prostate Cancer
  • Prostate Cancer Metastatic Disease
  • Prostate Cancer Metastatic to Bone
Interventions
  • RADIATION
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page